MediaPress Releases
 July 25, 2014

Sg2 to Speak at SHSMD Connections 2014

(Skokie, Ill.July 25, 2014) – Sg2, a leader in health care analytics and intelligence, today announced that Yelena Bouaziz, director of strategic analytics at Sg2, and Christina Thueme, director of strategic planning and market intelligence at Spectrum Health, will be co-presenters at SHSMD Connections 2014.

Bouaziz’s and Thueme’s presentation, Using Real Claims Data to Understand the Ambulatory Market, will take place Tuesday, October 14 from 1:30–2:30 pm PT at the Manchester Grand Hyatt in San Diego, California. In addition to speaking at the meeting, Sg2 will be showcasing its products and services at in the exhibit hall.

In their presentation, Bouaziz and Thueme will explore Spectrum Health’s pioneering analytics-driven ambulatory strategy and examine why accurate, complete, and timely ambulatory market intelligence is important for strategy. Bouaziz brings to Sg2 extensive expertise in strategic planning, facility development and performance improvement.

SHSMD Connections is a four-day event designed to help health care strategy professionals respond quickly to changes in your care delivery and plan ahead for the rapidly evolving future of health care.

What: Sg2 presentation at SHSMD Connections 2014
When: Tuesday, October 14 from 1:30–2:30 pm PT
Who: Yelena Bouaziz, Sg2 Director of Strategic Analytics, and Christina Thueme, Spectrum Health Director of Strategic Planning and Market Intelligence
Where: Manchester Grand Hyatt, San Diego, California


To learn more about Sg2 or to setup a time to speak with Yelena Bouaziz, please email

About Sg2 Sg2’s analytics-based health care expertise helps hospitals and health systems integrate, prioritize and drive growth and performance across the continuum of care. Over 1200 organizations around the world rely on Sg2’s analytics, intelligence, consulting and educational services.

For more information, visit


  • Share
  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube